Efficacy and Safety of Azathioprine during Remission of Immune-Mediated Thrombotic Thrombocytopenic Purpura

被引：0
|
作者：
Bichard, Christian [1 ]
Mancini, Ilaria [1 ]
Agosti, Pasquale [1 ]
De Leo, Pasqualina [2 ]
Artoni, Andrea [2 ]
Capecchi, Marco [2 ,3 ]
Trisolini, Silvia Maria [4 ]
Fozza, Claudio [5 ]
Peyvandi, Flora [1 ,2 ]
机构：
[1] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy
[2] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy
[3] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy
[4] Sapienza Univ, Div Hematol, Dept Translat & Precis Med, Rome, Italy
[5] Univ Sassari, Dept Clin & Expt Med, Sassari, Italy
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-150841
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
773
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Efficacy and safety of azathioprine during remission of immune-mediated thrombotic thrombocytopenic purpura
    Bichard, Christian
    Mancini, Ilaria
    Agosti, Pasquale
    Capecchi, Marco
    De Leo, Pasqualina
    Arcudi, Sara
    Ferrari, Barbara
    Trisolini, Silvia Maria
    Longu, Francesco
    Fozza, Claudio
    Artoni, Andrea
    Peyvandi, Flora
    BLOOD ADVANCES, 2022, 6 (18) : 5463 - 5466
  • [2] Efficacy and Safety of Obinutuzumab in Immune-Mediated Thrombotic Thrombocytopenic Purpura
    Weisinger, Julia
    Bouzid, Raida
    Fadlallah, Jehane
    Barbet, Christelle
    Provot, Francois
    Poullin, Pascale
    Neel, Antoine
    Marie, Manon
    Rieu, Virginie
    Kanouni, Tarik
    Moranne, Olivier
    Azoulay, Elie
    Marjanovic, Zora
    Corre, Elise
    Joly, Anne-Christine
    Baylatry, Minh-Tam
    Joly, Berangere S.
    Veyradier, Agnes
    Coppo, Paul
    French Natl Ctr Thrombotic Microangiopathies CNR-MAT
    AMERICAN JOURNAL OF HEMATOLOGY, 2024,
  • [3] Efficacy and safety of daratumumab in multiresistant immune-mediated thrombotic thrombocytopenic purpura
    Weisinger, Julia
    Bouzid, Raida
    Ranta, Dana
    Woaye-Hune, Pascal
    Cohen-Aubart, Fleur
    Gaible, Clotilde
    Marjanovic, Zora
    Corre, Elise
    Joly, Anne-Christine
    Baylatry, Minh-Tam
    Joly, Berangere S.
    Veyradier, Agnes
    Coppo, Paul
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (05) : 1951 - 1958
  • [4] Congenital and immune-mediated thrombotic thrombocytopenic purpura
    Hovinga, J. A. Kremer
    HAEMOPHILIA, 2018, 24 : 17 - 17
  • [5] Daratumumab for refractory immune-mediated thrombotic thrombocytopenic purpura
    Aggarwal, Asha
    White, Danielle
    Pavord, Sue
    Thomas, Will
    Desborough, Michael J. R.
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 202 (02) : 429 - 433
  • [6] IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA WITHOUT THROMBOCYTOPENIA
    Ul Abedin, Muhammad Shan
    Batool, Izza
    CHEST, 2024, 166 (04) : 2929A - 2930A
  • [7] Preemptive cyclosporin A in immune-mediated thrombotic thrombocytopenic purpura
    Comparon, Celine
    Galicier, Lionel
    Rebibou, Jean Michel
    Coppo, Paul
    Benhamou, Ygal
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 110 (02) : 157 - 160
  • [8] Laboratory surveillance of immune-mediated thrombotic thrombocytopenic purpura
    Li, Ang
    Hovinga, Johanna A. Kremer
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2020, (01) : 82 - 84
  • [9] Caplacizumab to treat immune-mediated thrombotic thrombocytopenic purpura
    Poullin, P.
    Bornet, C.
    Veyradier, A.
    Coppo, P.
    DRUGS OF TODAY, 2019, 55 (06) : 367 - 376
  • [10] Rituximab in the treatment of immune-mediated thrombotic thrombocytopenic purpura
    Ozpolat, Hasan Tahsin
    Stolla, Moritz
    BLOOD TRANSFUSION, 2023, 21 (05) : 369 - 374
12345